Hemopure hemoglobin glutamer: Phase IIb/III hold

Biopure said FDA placed a clinical hold on the U.S. Phase IIb/III RESUS trial, which was proposed by the Naval Medical Research Center (NMRC) and designed to enroll injured civilians. In 2006, an FDA...